Hägglund, H <br/><br/>
A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation.  [electronic resource] 

 -  Bone marrow transplantation  Oct 1999 
 - 831-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1701996  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Bone Marrow Transplantation<br/>Child<br/>Child, Preschool<br/>Female<br/>Filgrastim<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Hematologic Neoplasms--therapy<br/>Hematopoiesis--drug effects<br/>Histocompatibility Testing<br/>Humans<br/>Infant<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Recombinant Proteins<br/>Transplantation, Homologous<br/>Treatment Outcome